ISCHEMIA Trial and the Significance of MI

During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias, Eduardo A, Damas-de los Santos, Félix, Ontiveros-Mercado, Heriberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
Coronary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607381/
https://www.ncbi.nlm.nih.gov/pubmed/33163087
http://dx.doi.org/10.15420/icr.2020.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607381/
https://www.ncbi.nlm.nih.gov/pubmed/33163087
http://dx.doi.org/10.15420/icr.2020.15

Ejemplares similares